Topic: Daily Advice

Stock market: C.R. Bard’s earnings rise 9.1% in latest quarter

C.R. Bard Inc, symbol BCR on New York, makes medical devices in four main areas: vascular products (28% of sales) such as stents and catheters; oncology products (27%) that detect and treat various types of cancer; urology products (26%) such as drainage and incontinence devices; and surgical tools (16%). Other medical products supply the remaining 3%.

We analyze C.R. Bard in Wall Street Stock Forecaster, our newsletter for investing in the U.S. stock market.

In the first quarter of 2011, Bard’s sales rose 7.6%, to $700.3 million from $650.8 million a year earlier. Earnings gained 9.1% to $131.9 million, or $1.49 per share. The stock market pick earned $121.2 million, or $1.24 a share, a year earlier.

The company has several plans to spur its growth. For example, it aims to increase its international sales, which now account for 30% of total sales. As well, Bard wants to launch more new products. Research expenses of $48.0 million represented 6.9% of sales, compared with $40.6 million, or 6.2% of sales, in 2010. Bard intends to spend 7.5% of its sales on research in 2011.

If you invest in the U.S. stock market, you should subscribe to Wall Street Stock Forecaster. You can get the latest issue absolutely FREE when you subscribe now. Click here to learn how.

Comments

Tell Us What YOU Think

You must be logged in to post a comment.

Please be respectful with your comments and help us keep this an area that everyone can enjoy. If you believe a comment is abusive or otherwise violates our Terms of Use, please click here to report it to the administrator.